Stay updated on Bispecific Antibody MCLA-158 Clinical Trial

Sign up to get notified when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bispecific Antibody MCLA-158 Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Updated the label from 'Find Contact Information' to 'Find contact information', reflecting a capitalization refinement in the page UI. The revision tag changes from v3.6.6 to v3.7.0, indicating a minor version update.
    Difference
    0.1%
    Check dated 2026-09-15T23:55:11.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s implementation. This appears to be a behind-the-scenes maintenance update rather than a change to the study content shown on the page.
    Difference
    0.0%
    Check dated 2026-09-01T20:52:00.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    An NIH grant/contract identifier was added to the study's identifiers, linking the trial to U.S. NIH funding.
    Difference
    0.0%
    Check dated 2026-08-25T21:29:21.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5 on the page. This appears to be a minor metadata/patch update and does not change study data or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-11T21:48:56.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page adds details about new expansion cohorts and dosing (RP2D of 1500 mg every 2 weeks for single-agent MCLA-158) and outlines planned combination cohorts with pembrolizumab, FOLFIRI, and FOLFOX. It also updates recruitment sites, investigators, and contact information across many locations.
    Difference
    6%
    Check dated 2026-08-04T17:33:51.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page, signaling a minor update to the study details page. No substantive study data or user-visible content appears to be changed.
    Difference
    0.0%
    Check dated 2026-07-28T15:13:57.000Z thumbnail image

Stay in the know with updates to Bispecific Antibody MCLA-158 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.